High-Dose MTX Does Not Reduce CNS Relapse in Pediatric ALL

The UKALL2011 study also showed that a shorter course of dexamethasone did not reduce toxicities, and that monthly pulses of vincristine/dexamethasone don't reduce bone marrow relapse.
Medscape Medical News

source https://www.medscape.com/viewarticle/985385?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?